arrow
F

Francesca Fumagalli

IRCCS San Raffaele Scientific Institute
H指数:17
被引数:2,839

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Allogeneic haematopoietic stem cell transplantation in late-onset metachromatic leukodystrophy

异基因造血干细胞移植在迟发性异染性脑白质营养不良中的应用

Brain
IF11.7
2026-09-210
PRE
Preliminary Data of the First Year of Newborn Screening for Metachromatic Leukodystrophy (MLD) in Lombardy

意大利伦巴第地区新生儿筛查中异染性脑白质营养不良(MLD)第一年的初步数据

2026-07-020
OAAI
Newborn Screening for Metachromatic Leukodystrophy in Tuscany: The Paradigm of a Successful Preventive Medicine Program

托斯卡纳地区进行异染性脑白质营养不良的新生儿筛查:一个成功的预防医学项目的范例

2025-09-290
OAAI
Non-neurological, non skeletal outcomes after hematopoietic stem and progenitor cell-gene therapy -OTL-203- for Hurler syndrome

非神经性、非骨骼结局:用于Hurler综合征的造血干细胞及祖细胞-基因疗法-OTL-203

2025-09-270
PRE
Newborn Screening for Metachromatic Leukodystrophy in Tuscany: The Paradigm of a Successful Preventive Medicine Program

托斯卡纳地区异染性脑白质营养不良的新生儿筛查:一个成功预防医学项目的范例

2025-08-210
PRE
ARSA Variants Associated With Cognitive Decline and Long-Term Preservation of Motor Function in Metachromatic Leukodystrophy

ARSA变体与认知能力下降及异染性脑白质营养不良中运动功能的长期维持相关

2025-08-020
OA
Hematopoietic stem cell gene therapy for mucopolysaccharidosis type I-Hurler syndrome (OTL-203): Interim skeletal, neurological and systemic outcomes from a phase I/II study
2025-02-010
PRE
Atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy) preserves cognition, language, and speech and slows brain demyelination and atrophy in early-onset metachromatic leukodystrophy
2025-02-010
PRE
Gene therapy in advanced metachromatic leukodystrophy: tempering expectations
2024-11-280
OAAI
Long-term lineage commitment in haematopoietic stem cell gene therapy

造血干细胞基因治疗中的长期谱系承诺

Nature
IF48.5
2024-10-230
OAAI
Developmental delay can precede neurologic regression in early onset metachromatic leukodystrophy
2024-08-010
PRE
Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States
2024-07-017
PRE
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
2024-05-012
PRE
Lentiviral hematopoietic stem cell gene therapy (atidarsagene autotemcel) for late juvenile metachromatic leukodystrophy (MLD)
2024-02-010
PRE
Atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy) preserves cognitive and motor development in early-onset metachromatic leukodystrophy with up to 12 years follow-up
2024-02-010
PRE
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)
2022-02-1416
OAAI